Pages that link to "Q40204129"

The following pages link to A prediction model for bacterial etiology in acute exacerbations of COPD. (Q40204129):

Displaying 28 items.

• Lung microbiology and exacerbations in COPD (Q22305860) (← links)
• Pulmonary-intestinal cross-talk in mucosal inflammatory disease (Q27693862) (← links)
• Treatment of patients with COPD and recurrent exacerbations: the role of infection and inflammation (Q28071694) (← links)
• Guidelines for the management of adult lower respiratory tract infections - Full version (Q28249185) (← links)
• Cigarette smoke decreases airway epithelial FABP5 expression and promotes Pseudomonas aeruginosa infection (Q28393450) (← links)
• N-acetylcysteine inhibit biofilms produced by Pseudomonas aeruginosa (Q33576307) (← links)
• Pseudomonas aeruginosa isolates in severe chronic obstructive pulmonary disease: characterization and risk factors. (Q33889496) (← links)
• Antibiotics against Pseudomonas aeruginosa for COPD exacerbation in ICU: a 10-year retrospective study (Q35110953) (← links)
• Quantitative analysis of pathogens in the lower respiratory tract of patients with chronic obstructive pulmonary disease (Q35749457) (← links)
• A predictive model for the development of chronic obstructive pulmonary disease (Q36321481) (← links)
• Antibiotic therapy for exacerbations of chronic obstructive pulmonary disease (COPD). (Q37814698) (← links)
• Chronic obstructive pulmonary disease (COPD) and old age? (Q37877440) (← links)
• Chronic bronchial infection in COPD. Is there an infective phenotype? (Q38065457) (← links)
• Relationship Between Severity Classification of Acute Exacerbation of Chronic Obstructive Pulmonary Disease and Clinical Outcomes in Hospitalized Patients (Q38925964) (← links)
• Increased Myeloid Cell Production and Lung Bacterial Clearance in Mice Exposed to Cigarette Smoke (Q41052114) (← links)
• Effectiveness of treatment with nebulized colistin in patients with COPD (Q42373825) (← links)
• The antibacterial and antifungal properties of trappin-2 (pre-elafin) do not depend on its protease inhibitory function. (Q46701553) (← links)
• Pseudomonas aeruginosa resistance patterns and clinical outcomes in hospitalized exacerbations of COPD. (Q48051439) (← links)
• Pseudomonas aeruginosa in chronic obstructive pulmonary disease. (Q54550554) (← links)
• A Comparison between Two Pathophysiologically Different yet Microbiologically Similar Lung Diseases: Cystic Fibrosis and Chronic Obstructive Pulmonary Disease (Q60928130) (← links)
• Mortality of COPD Patients Infected with Multi-Resistant Pseudomonas aeruginosa: A Case and Control Study (Q61766695) (← links)
• Impact of fatty acid binding protein 5-deficiency on COPD exacerbations and cigarette smoke-induced inflammatory response to bacterial infection (Q64086226) (← links)
• Tobacco exposure inhibits SPLUNC1-dependent antimicrobial activity (Q64275912) (← links)
• [Chronic obstructive pulmonary disease and bronchiectasias] (Q84556828) (← links)
• Treatment effects of Co-amoxiclav (Amoxiclav 2x) in acute exacerbation of severe chronic obstructive pulmonary disease: Clinical evaluation (Q84924255) (← links)
• Lower Airway Bacterial Colonization Patterns and Species-Specific Interactions in Chronic Obstructive Pulmonary Disease (Q90473547) (← links)
• Personalized medicine for patients with COPD: where are we? (Q92354134) (← links)
• Impact of Pseudomonas aeruginosa Isolation on Mortality and Outcomes in an Outpatient Chronic Obstructive Pulmonary Disease Cohort (Q93016987) (← links)